Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.95 CHF | +0.68% | +5.48% | +9.33% |
01:37pm | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.33% | 208B | |
+29.25% | 684B | |
+29.16% | 568B | |
-3.96% | 361B | |
+18.64% | 329B | |
+4.68% | 284B | |
+16.02% | 240B | |
-6.99% | 200B | |
+7.84% | 166B | |
-1.48% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : UBS reiterates its Neutral rating